Concentrated mixture of boswellic acids and high bioavailability curcuminoids
Concentrated mixture of polyphenols, catechins and polyunsaturated fatty acids with antioxidant activity
Mixture of high bioavailability curcuminoids with increased selectivity for nerve tissues
Mixture of Klamath microalgae with a high concentration of minerals, vitamins, amino acids and nutraceutical molecules, such as phenylethylamine, phycocyanins, polyunsaturated fatty acids
Mixture based on nanoparticles for the conveyance of different polyphenols with antioxidant activity
We study with those at the top of the class.
Our collaborations with top national and international research centers represent a valuable source of clinical experimentation, thematic investigation and technological progress. This dialogue with leading centers of excellence throughout the world enables us to select and verify active ingredients based on objective evidence, and transform them into food supplements and therapeutic solutions with proven efficacy.
Some of our key collaborations and clinical studies:
- Promotion of the Meeting entitled “From Oxidative Stress to Retinal Ganglion Cell Death”, with the co-participation of international doctors and researchers to discuss the latest findings on the pathogenesis of glaucoma.
An international multi-center placebo controlled randomized clinical study in collaboration with:
- Regional Reference Center – Rapallo Hospital – Genoa – Dr. Pia Allegri, Resp. SSD Uveitis and Ocular Inflammations
- Santa Maria Nuova Hospital – Reggio Emilia – Dr. Luca Cimino, Head of Uveitis and Ocular Inflammations SSD
- University of Miami – Bascom Palmer Eye Institute – Resp. SSD – Dr. Janet Davis, Professor of Ophthalmology
- Istanbul University: Uveiti project, in collaboration with Dr. Ilknur Tugal-Tutkun, Professor of Ophthalmology – Resp SSD Uveiti
- University of Naples Federico II: Study on Macular Edema in Diabetic Patients with Ophthalmology Department.
- Polo Universitario University of Milan: collaboration with Dr. G. Staurenghi, Head of Ophthalmology, Luigi Sacco Hospital. Study carried out with the product Nolfo for the prevention of macular degeneration, in particular when the disease is still in the pseudo-drusen phase.
- University of Genoa, Department of Experimental Medicine (DIMES) Prof. A. Bassi, with the contribution of the University Clinic of Parma, Director Prof. Gandolfi: Use of an Innovative 3D Model of the Trabecularis for the in Vitro Study of Processes Related to the Pathogenesis of Glaucoma.
- University of Genoa: Development of a tool for the early diagnosis of glaucoma, through the use of a microbalance (qcm) capable of measuring the presence of a certain protein in a sample of aqueous humor, on sensors properly functionalized for this purpose. This project led to the obtaining of a patent on the device. The startup Novaetech and the Swiss company aeChem also took part in this study.
- University of Genoa: Project for the development of new eye drops with a high concentration of polyphenols (Drain drops) or with the use of particular nanoparticles, which have been developed together with Yun Wu, Associate Professor of the Department of Biomedical Engineering, University at Buffalo, The State University of New York.
- University of Genoa: Two in vitro studies for the development of our Regenera therapeutic lenses. These studies helped to analyze the release processes of Aloe in which the lens is soaked, as well as to better understand the type of interaction that the lens has with different eye drops (anti-inflammatory, cortisone and antibiotics).